Zomedica shareholders reject advisory vote on executive compensation at 2024 annual meeting

Zomedica Corp.

Advisory 'say-on-pay' resolution failed: 79,412,285 for vs. 88,436,460 against, plus 183,131,919 broker non-votes.
All eight director nominees elected; votes ranged from 103.6M to 117.6M for, with broker non-votes of ~183.1M.
Ratification of Grant Thornton LLP as auditor for 2024 passed: 288,330,513 for, 67,093,805 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.